Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04273282 · ClinicalTrials.gov registry record · Phase 4
A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1%
A Phase 4 study, sponsored by Research Insight.
- Completed
- Registry status
- Phase 4
- Development phase
- 31
- Enrollment target
NCT04273282 is a Phase 4 study that has completed, run by Research Insight. The registered enrollment target is 31 participants.
The verdict
NCT04273282, a Phase 4 study, has completed, sponsored by Research Insight.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 31 participants
- Enrollment target
Study Summary
This is a post-approval, open-label, randomized, self-controlled prospective clinical study to evaluate the safety and ocular efficacy of Dexycu in controlling postoperative ocular pain and inflammation associated with cataract surgery.
Interventions
- DRUG Prednisolone Acetate
- DRUG Dexycu intracameral dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2019-12-16 |
| Est. Completion | 2020-11-24 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04273282
The ClinicalTrials.gov registry entry for NCT04273282 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Research Insight, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prednisolone Acetate is the first listed.
NCT04273282 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04273282 about?
NCT04273282 is a clinical study titled "A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1%". This is a post-approval, open-label, randomized, self-controlled prospective clinical study to evaluate the safety and ocular efficacy of Dexycu in controlling postoperative ocular pain and inflammation associated with cataract surgery.
What is the current status of trial NCT04273282?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 31 participants. The study started on 2019-12-16. Estimated completion is 2020-11-24.
What interventions are being tested in trial NCT04273282?
The interventions under investigation include: Prednisolone Acetate (DRUG), Dexycu intracameral dexamethasone (DRUG).
Who is sponsoring clinical trial NCT04273282?
This trial is sponsored by Research Insight, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.